Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 1Obesity 1Lipid Metabolism Disorders 1Diabetes Mellitus 1Cardiovascular Diseases 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Metformin 8Letrozole 3Pharmaceutical Preparations 2semaglutide 1salicylsalicylic acid 1mirabegron 1drospirenone and ethinyl estradiol combination 1Vitamins 1Thioctic Acid 1Progesterone 1Itraconazole 1Inositol 1Hydroquinones 1Gonadotropin-Releasing Hormone 1Flutamide 1Flour 1Fish Oils 1Docosahexaenoic Acids 1Clomiphene 1Ascorbic Acid 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Polycystic Ovary Syndrome × Docosahexaenoic Acids × Clear all
NCT04116203 2025-02-28

PCOS

University of Alberta

Phase 1 Completed
52 enrolled
Other

Cardiovascular Diseases, Diabetes Mellitus, Obesity, Polycystic Ovary Syndrome, Lipid Metabolism Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡